Findings of our study identify TF and TFPI as potential markers for advanced subclinical atherosclerosis in HIV-infected patients and could have practical applications in primary prevention of cardiovascular diseases in people living with HIV. The gene discussed is TFPI; the disease is atherosclerosis.